Draft Guideline-Centers for Disease Control and Prevention Draft Guideline for the Prevention of Surgical Site Infections
Federal Register, Volume 79 Issue 19 (Wednesday, January 29, 2014)
Federal Register Volume 79, Number 19 (Wednesday, January 29, 2014)
Notices
Pages 4724-4725
From the Federal Register Online via the Government Printing Office www.gpo.gov
FR Doc No: 2014-01674
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Docket No. CDC-2014-0003
Draft Guideline--Centers for Disease Control and Prevention Draft Guideline for the Prevention of Surgical Site Infections
AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS).
ACTION: Notice of availability and request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS) requests public comment on the Draft Guideline for the Prevention of Surgical Site Infections (SSIs) (draft Guideline). The Draft Guideline addresses new and updated strategies for the prevention of SSI in healthcare settings. This draft Guideline can be found at http://www.regulations.gov Docket No. CDC-2014-0003. CDC is also publishing the supporting appendices that include primary evidence, study evaluation, and data evaluation tables that were used in developing the draft Guideline recommendations at http://www.regulations.gov.
The draft Guideline is designed for use by infection prevention staff, healthcare epidemiologists, administrators, nurses, and personnel responsible for developing, implementing, and evaluating infection prevention and control programs for healthcare settings across the continuum of care. The recommendations contained in the draft Guideline are based on a targeted systematic review of the best available evidence for specific topics related to the prevention of surgical site infections (SSI).
DATES: Comments must be received on or before February 28, 2014.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2014-
0003, by any of the following methods:
Federal eRulemaking Portal: http://www.regulations.gov. Follow the instructions for submitting comments.
Mail: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Attn: Guideline for the Prevention of Surgical Site Infections, Docket No. CDC-2014-0003, 1600 Clifton Road NE., Mailstop A07, Atlanta, Georgia 30333.
Instructions: All submissions received must include the agency name and docket number or RIN. All relevant public comments received will be posted publicly to www.regulations.gov without change, including any personal or proprietary information provided. To download an electronic version of the draft Guideline and appendices, access http://www.regulations.gov.
Written materials identified by Docket No. CDC-2014-0003 will be available during the comment period for public inspection Monday through Friday, except for legal holidays, 9 a.m. until 4:30 p.m. Eastern Standard Time, at CDC Library, 1600 Clifton Road NE., Atlanta, Georgia 30333. Please call ahead to (404) 639-1717 and request a Library representative schedule your visit. All public comments will be reviewed and considered prior to finalizing the draft Guideline.
FOR FURTHER INFORMATION CONTACT: Erin Stone, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop A-31, Atlanta, Georgia 30333; Telephone: (404) 639-4000.
SUPPLEMENTARY INFORMATION: Since 2010 CDC has collaborated with national partners, academicians, public and private health professionals, and other partners to create this draft Guideline. Additionally, CDC sought input in each phase of development from subject matter experts in surgery, infectious diseases, and orthopedics through a Guideline Expert Panel formed to develop the new draft Guideline. CDC also received input from the Healthcare Infection Control Practices Advisory Committee (HICPAC) throughout the development of the draft Guideline. HICPAC includes representatives from public health,
Page 4725
infectious diseases, regulatory and other federal agencies, professional societies, and other stakeholders. This new draft Guideline will not be a federal rule or regulation.
Dated: January 22, 2014.
Stacey Hoffman,
Acting Director, Division of Executive Secretariat Centers for Disease Control and Prevention.
FR Doc. 2014-01674 Filed 1-28-14; 8:45 am
BILLING CODE 4163-18-P
